Select for export US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.acepjo.2025.100231 PubMed 40927687 Copy citation Copy BibTeX Journal of the American College of Emergency Physicians Open 2025-08-29 Juan Carlos C. Montoy, Ralph C. Wang, Allison R. Coker, Craig G. Smollin, B. Anderson OpenAlex Published psilocybin SafetyToxicity Other More
Select for export Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03556-4 PubMed 40883271 Copy citation Copy BibTeX Translational Psychiatry 2025-08-28 Anton L.V. Avanceña, Linh N. Vuong, James G. Kahn, Elliot Marseille OpenAlex Published psilocybin DepressionReceptor PharmacologyTreatment-Resistant Depression Other More
Select for export Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251362390 PubMed 40883964 Copy citation Copy BibTeX Journal of Psychopharmacology 2025-08-28 Niall M. McGowan, James Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons OpenAlex Published psilocybin DepressionPTSDChronic Pain Clinical Trial More
Select for export A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD) Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-08-27 Nathan Brashares Sackett ClinicalTrials.gov CLINICAL TRIAL psilocybin PTSDAddictionClinical Trial Clinical Trial More
Select for export Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2024.0031 PubMed 40933206 Copy citation Copy BibTeX Unknown journal 2025-08-27 Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Rejuvenation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31124/advance.175630073.36585408/v1 Copy citation Copy BibTeX Unknown journal 2025-08-26 Tony Montgomery, DeMond M. Grant OpenAlex Published psilocybin NeuroplasticityMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Psychedelic minimalism: the case against music in psychedelic therapy settings Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2025.1652568 PubMed 40933801 Copy citation Copy BibTeX Frontiers in Psychiatry 2025-08-25 Samir A Nader OpenAlex Published psilocybin AnxietyConsciousnessPersonality Change Clinical Trial More
Select for export Psilocybin: Systematic review of its use in the treatment of depression No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2025-08-25 Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C Europe PMC Published psilocybin DepressionSystematic ReviewReview Article Systematic Review More
Select for export Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-025-03169-9 PubMed 40849544 Copy citation Copy BibTeX Unknown journal 2025-08-22 Drewko AJ, Habets RLP, Brunt TM. Europe PMC Published psilocybin DepressionNeuroplasticityMechanism of Action Review Article More
Select for export Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-7420529/v1 Copy citation Copy BibTeX Research Square 2025-08-21 Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionEmotional ProcessingMystical Experience Clinical Trial More
Select for export Psychedelics and the Serotonin Hypothesis of Eating Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/brainsci15080893 PubMed 40867224 Copy citation Copy BibTeX Unknown journal 2025-08-20 Bilenker D, Avena NM. Europe PMC Published psilocybin Eating DisordersNeuroplasticityBrain Imaging Clinical Trial More
Select for export Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-08-19 Centre Hospitalier Universitaire de Nīmes ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionBrain ImagingMechanism of Action Other More
Select for export Effects of Psilocybin in Post-Treatment Lyme Disease Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-08-19 Johns Hopkins University ClinicalTrials.gov CLINICAL TRIAL psilocybin General Other More
Select for export Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians. No abstract availability was recorded for this entry. Details DOI 10.1177/00912174251369880 PubMed 40833259 Copy citation Copy BibTeX Unknown journal 2025-08-19 Koenig HG. Europe PMC Published psilocybin DepressionSafety Other More
Select for export A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-08-18 COMPASS Pathways ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionPharmacologyClinical Trial Clinical Trial More
Select for export Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-6941009/v1 Copy citation Copy BibTeX Research Square 2025-08-18 Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE. Europe PMC PREPRINT (not peer reviewed) psilocybin End-of-Life DistressObservational StudyCancer Patients Observational Study More
Select for export Exploring the therapeutic potential of psychedelics in treating substance use disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-025-03168-w PubMed 40830580 Copy citation Copy BibTeX Unknown journal 2025-08-18 Li Y, Li H, Wang H, Wang X. Europe PMC Published psilocybin AddictionNeuroplasticityClinical Trial Clinical Trial More
Select for export Psychedelic-assisted therapies for existential and spiritual suffering in palliative care. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.pbr.2025.07.002 PubMed 40967680 Copy citation Copy BibTeX Unknown journal 2025-08-17 Garcia ACM, Maia LO. Europe PMC Published psilocybin End-of-Life DistressMechanism of ActionSpirituality Review Article More
Select for export Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.90425 PubMed 40970030 Copy citation Copy BibTeX Unknown journal 2025-08-17 Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N Europe PMC Published psilocybin DepressionAnxietyPTSD Meta-Analysis More
Select for export Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.08.13.25333530 Copy citation Copy BibTeX medRxiv 2025-08-15 Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT medRxiv PREPRINT (not peer reviewed) psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More